ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 133 filers reported holding ANAPTYSBIO INC in Q3 2020. The put-call ratio across all filers is 62.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,335,000 | -29.8% | 53,963 | -1.5% | 0.00% | 0.0% |
| Q4 2021 | $1,903,000 | +22.5% | 54,757 | -4.4% | 0.00% | 0.0% |
| Q3 2021 | $1,553,000 | +18.0% | 57,279 | +12.9% | 0.00% | 0.0% |
| Q2 2021 | $1,316,000 | +13.3% | 50,735 | -5.9% | 0.00% | 0.0% |
| Q1 2021 | $1,162,000 | +15.2% | 53,938 | +14.9% | 0.00% | 0.0% |
| Q4 2020 | $1,009,000 | +83.5% | 46,935 | +25.9% | 0.00% | – |
| Q3 2020 | $550,000 | -26.5% | 37,288 | +11.4% | 0.00% | -100.0% |
| Q2 2020 | $748,000 | +10.5% | 33,461 | -30.1% | 0.00% | 0.0% |
| Q1 2020 | $677,000 | +13.0% | 47,877 | +29.8% | 0.00% | – |
| Q4 2019 | $599,000 | +93.9% | 36,889 | +318.0% | 0.00% | – |
| Q3 2019 | $309,000 | -4.0% | 8,826 | +54.5% | 0.00% | – |
| Q2 2019 | $322,000 | +58.6% | 5,714 | +181.2% | 0.00% | – |
| Q3 2018 | $203,000 | – | 2,032 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,950,609 | $35,032,938 | 4.94% |
| EcoR1 Capital, LLC | 7,521,024 | $135,077,591 | 4.56% |
| Saturn V Capital Management LP | 577,101 | $10,364,734 | 4.34% |
| GREAT POINT PARTNERS LLC | 894,333 | $16,062,221 | 2.93% |
| 5AM Venture Management, LLC | 357,733 | $6,424,885 | 1.85% |
| First Light Asset Management, LLC | 790,806 | $14,202,876 | 1.35% |
| Boxer Capital, LLC | 1,300,000 | $23,348,000 | 1.24% |
| Frazier Life Sciences Management, L.P. | 899,700 | $16,158,612 | 1.07% |
| Deep Track Capital, LP | 1,345,813 | $24,170,801 | 0.93% |
| Palo Alto Investors LP | 431,224 | $7,744,783 | 0.73% |